• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Inhibitory effect of losartan on prostatic hyperplasia in spontaneous hypertension rats and its pathophysiological mechanism].

作者信息

Shen Fang, Dong Li-Ni, Zhang Xiang-Yu, Zhao Xiao-Kun, Zeng Xiao-Fang, Qu Xiao-Bing

机构信息

The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.

出版信息

Zhonghua Nan Ke Xue. 2012 Jul;18(7):600-5.

PMID:22994044
Abstract

OBJECTIVE

To investigate the effect of losartan on prostatic hyperplasia in spontaneous hypertension rats (SHRs) and its pathophysiological mechanism.

METHODS

We randomly divided 36 male SHRs into three groups of equal number to be treated intragastrically with high-dose losartan (30 mg per kg per d), low-dose losartan (15 mg per kg per d) and distilled water (control group). After 6 weeks of intervention, we measured the body weight and tail artery blood pressure of the rats and compared them with the baseline data. We collected blood from the heart for determination of the levels of serum angiotensin II (Ang II), insulin-like growth factor-1 (IGF-1) and interleukin-6 (IL-6) by enzyme-linked immunosorbent assay (ELISA), and harvested their prostates for measurement of their weight, observation of the tissue ultrastructures under the electron microscope and detection of the expression of endothelial nitric oxide synthase (eNOS) in the prostate tissue by immunohistochemistry.

RESULTS

Compared with the control group, the low- and high-dose losartan groups showed significant decreases in systolic blood pressure ([203.75 +/- 10.28] vs [184.54 +/- 16.90] mmHg, P = 0.013; [203.75 +/- 10.28] vs [166.88 +/- 14.74] mmHg, P = 0.001) and diastolic blood pressure ([151.58 +/- 9.96] vs [136.71 +/- 14.28] mmHg, P = 0.022; [151.58 +/- 9.96] vs [122.71 +/- 11.56] mmHg, P < 0.001) of the lower tail artery after treatment, as well as in the prostate weight ([0.73 +/- 0.08] vs [0.64 +/- 0.10] mg, P = 0.011; [0.73 +/- 0.08 ] vs [0.50 +/- 0.17] mg, P < 0.001). Electron microscopy revealed edema of the basal and columnar epithelial cells, concentrated and marginated heterochromatin and widened nuclear gap of interstitial fibroblast nuclei, and reduced mitochondria and endoplasmic reticula in the low-dose losartan group, and even more obvious in the high-dose group. The level of serum Ang II was remarkably higher in the low- and high-dose losartan groups than in the control ([61.32 +/- 2.49] vs [54.85 +/- 7.20] pg/ml, P = 0.021; [65.49 +/- 6.78] vs [54.85 +/- 7.20] pg/ml, P < 0.001]) , that of serum IGF-1 was lower in high-dose losartan than in the control group ([1.50 +/- 0.11] vs [1.60 +/- 0.10] ng/ml, P = 0.03), but the serum IL-6 levels exhibited no significant differences among the three groups. The expression of eNOS in the prostate tissue was significantly higher in the losartan groups than in the controls (P = 0.022), even higher in the high-dose than in the low-dose group.

CONCLUSION

Losartan can suppress the progression of prostate hyperplasia in spontaneous hypertension rats by inhibiting RAS, IGF-1 and angiogenesis.

摘要

相似文献

1
[Inhibitory effect of losartan on prostatic hyperplasia in spontaneous hypertension rats and its pathophysiological mechanism].
Zhonghua Nan Ke Xue. 2012 Jul;18(7):600-5.
2
Influence and pathophysiological mechanisms of simvastatin on prostatic hyperplasia in spontaneously hypertensive rats.辛伐他汀对自发性高血压大鼠前列腺增生的影响及病理生理机制
Urol Int. 2013;91(4):467-73. doi: 10.1159/000350519. Epub 2013 Jul 6.
3
Angiotension II receptor 1 blocker modifies the expression of apoptosis-related proteins and transforming growth factor-beta1 in prostate tissue of spontaneously hypertensive rats.血管紧张素II受体1阻滞剂改变自发性高血压大鼠前列腺组织中凋亡相关蛋白和转化生长因子-β1的表达。
BJU Int. 2007 Nov;100(5):1161-5. doi: 10.1111/j.1464-410X.2007.07150.x. Epub 2007 Sep 3.
4
[Effects of losartan, ramipril and their combination on left ventricular remodeling and function in spontaneous hypertensive rats].氯沙坦、雷米普利及其联合应用对自发性高血压大鼠左心室重构和功能的影响
Zhonghua Yi Xue Za Zhi. 2005 Nov 30;85(45):3199-204.
5
Protective effects of the angiotensin II type 1 (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats.血管紧张素II 1型(AT1)受体阻断对低肾素醋酸脱氧皮质酮(DOCA)处理的自发性高血压大鼠的保护作用。
Clin Sci (Lond). 2004 Mar;106(3):251-9. doi: 10.1042/CS20030299.
6
Therapeutic effects of losartan on prostatic hyperplasia in spontaneously hypertensive rats.氯沙坦对自发性高血压大鼠前列腺增生的治疗作用。
Life Sci. 2021 Feb 1;266:118924. doi: 10.1016/j.lfs.2020.118924. Epub 2020 Dec 19.
7
Apoptosis, myocardial fibrosis and angiotensin II in the left ventricle of hypertensive rats treated with fosinopril or losartan.福辛普利或氯沙坦治疗的高血压大鼠左心室中的细胞凋亡、心肌纤维化与血管紧张素II
Chin Med J (Engl). 2002 Sep;115(9):1287-91.
8
Novel mechanism of intra‑renal angiotensin II-induced sodium/proton exchanger 3 expression by losartan in spontaneously hypertensive rats.氯沙坦对自发性高血压大鼠肾内血管紧张素II诱导的钠/质子交换体3表达的新机制
Mol Med Rep. 2014 Nov;10(5):2483-8. doi: 10.3892/mmr.2014.2492. Epub 2014 Aug 14.
9
Transforming growth factor beta1 mediates apoptotic activity of angiotensin II type I receptor blocker on prostate epithelium in vitro.转化生长因子-β1介导血管紧张素 II 型 1 型受体阻滞剂对前列腺上皮细胞的凋亡作用。
Prostate. 2010 Jun 1;70(8):899-905. doi: 10.1002/pros.21124.
10
Effects of long-term losartan and L-arginine treatment on haemodynamics, glomerular filtration, and SOD activity in spontaneously hypertensive rats.长期氯沙坦和L-精氨酸治疗对自发性高血压大鼠血流动力学、肾小球滤过及超氧化物歧化酶活性的影响。
Can J Physiol Pharmacol. 2008 Apr;86(4):210-4. doi: 10.1139/Y08-022.

引用本文的文献

1
Insights into the associative role of hypertension and angiotensin II receptor in lower urinary tract dysfunction.探讨高血压和血管紧张素Ⅱ受体在下尿路功能障碍中的关联作用。
Hypertens Res. 2024 Apr;47(4):987-997. doi: 10.1038/s41440-024-01597-8. Epub 2024 Feb 14.